Adding cetuximab to RT: ahead for cost effectiveness in Taiwan
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.640, 2011-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cetuximab ahead in head and neck cancer?
Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. :